Total Payments
$905.30
2024 Payments
$647.68
Companies
13
Transactions
55
Payment Breakdown by Category
Food & Beverage$905.30 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $905.30 | 55 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $287.48 | 18 | $0 (2024) |
| ABBVIE INC. | $200.94 | 14 | $0 (2024) |
| Novo Nordisk Inc | $73.68 | 5 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $58.03 | 2 | $0 (2024) |
| PFIZER INC. | $49.86 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $47.62 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $43.18 | 3 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $39.41 | 1 | $0 (2024) |
| Axsome Therapeutics, Inc. | $37.66 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $23.13 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $647.68 | 38 | Lilly USA, LLC ($197.49) |
| 2023 | $257.62 | 17 | Lilly USA, LLC ($89.99) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX, BEXSERO | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $31.30 | General |
| Category: PSYCHIATRY | ||||||
| 11/01/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY, BEXSERO | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: VACCINES | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: PSYCHIATRY | ||||||
| 09/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Diabetes | ||||||
| 06/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Diabetes | ||||||
| 05/15/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Obesity | ||||||
| 05/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: NEUROSCIENCE | ||||||
About Devin Comte, NP
Devin Comte, NP is a Family healthcare provider based in Lafayette, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2023. The National Provider Identifier (NPI) number assigned to this provider is 1386341816.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Devin Comte, NP has received a total of $905.30 in payments from pharmaceutical and medical device companies, with $647.68 received in 2024. These payments were reported across 55 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($905.30).
Ad
Practice Information
- Specialty Family
- Location Lafayette, IN
- Active Since 02/15/2023
- Last Updated 08/08/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1386341816
Products in Payments
- MOUNJARO (Drug) $238.73
- VRAYLAR (Drug) $174.38
- JARDIANCE (Drug) $78.55
- CAPLYTA (Drug) $72.20
- NURTEC ODT (Drug) $49.86
- Wegovy (Drug) $44.88
- XYWAV (Drug) $39.41
- Auvelity (Drug) $37.66
- UBRELVY (Drug) $26.56
- LEQVIO (Drug) $23.13
- SHINGRIX (Biological) $19.07
- Veozah (Drug) $16.88
- Ozempic (Drug) $15.76
- AREXVY (Drug) $14.88
- TRELEGY ELLIPTA (Drug) $13.67
- Cologuard Collection Kit (Device) $13.26
- Rybelsus (Drug) $13.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Lafayette
Rebekah Garrard, Fnp, FNP
Family — Payments: $69,457
Family $69,457
Shanna Johnson
Family — Payments: $20,789
Family $20,789
Mr. Bryant Dronette, Pmhnp-Bc, PMHNP-BC
Family — Payments: $11,968
Family $11,968
Mrs. Layne Lemaire, Fnp-C, FNP-C
Family — Payments: $9,853
Family $9,853
Lore-Lyndsey Moran, Pmhnp-Fnp-C, PMHNP-FNP-C
Family — Payments: $9,616
Family $9,616
Anna Faulk, Aprn, APRN
Family — Payments: $8,512
Family $8,512